Trials / Completed
CompletedNCT06266000
Comparison of 2 Extracts of Saw Palmetto Versus Placebo on Lower Urinary Tract Symptoms (LUTS) and Urinary Frequency
A Study to Compare 2 Extracts of Saw Palmetto Versus Placebo on Lower Urinary Tract Symptoms (LUTS) and Urinary Frequency
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 89 (actual)
- Sponsor
- RDC Clinical Pty Ltd · Industry
- Sex
- Male
- Age
- 45 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A randomized, double-blind, placebo-controlled, parallel group study to compare 2 extracts of saw palmetto versus placebo on lower urinary tract symptoms and urinary frequency in 120 generally healthy participants, 45 - 80 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Saw palmetto extract 320mg per day | Saw palmetto extract 160mg per capsule |
| DRUG | Commercial Saw palmetto extract 320mg per day | Saw palmetto extract 160mg per capsule |
| DRUG | Palm Oil capsule | Palm oil capsule |
Timeline
- Start date
- 2024-06-21
- Primary completion
- 2025-06-04
- Completion
- 2025-06-04
- First posted
- 2024-02-20
- Last updated
- 2025-08-20
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT06266000. Inclusion in this directory is not an endorsement.